Dr. Daniel S. Berman

[email protected]

Nuclear Medicine

Screening for CAD in diabetics: Which patient? Which test?

Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.

April 16, 2009

2007 04 11 12 05 10 706

Page 1 of 1

Representative DMI data from a patient with a high-grade glioma. DMI ratio maps pre- and post-treatment show spatial metabolic changes. Deuterium spectra from the tumor and contralateral NABP demonstrate metabolic differences and therapeutic effects.

ISMRM: DMI detects treatment response in patients with high-grade gliomas

Deuterium is a stable, nontoxic isotope used to label glucose, which is then administered as an oral imaging agent.

Kathryn Keenan, PhD

ISMRM: Kathryn Keenan on collaboration between rads and physicists

Ismrm Thumbnail

ISMRM: Cardiac MRI key to assessing CVD risk in those with HIV

Joshita Majumdar, PhD candidate in electrical and computer engineering, presented a snapshot of 7T MRI research based at the Auburn University Neuroimaging Center in Alabama. Other team members not pictured include Nguyen Phuoc Huynh and Adil Bashir, PhD, both of Auburn’s Samuel Ginn College of Engineering, and Lavanya Sankaran of California Health Sciences University in Fresno, CA.

ISMRM: 7T MR spectroscopy uncovers sleep-neurotransmitter dynamics

Turning Innovation into Everyday Efficiency

Turning Innovation into Everyday Efficiency

ISMRM: DMI detects treatment response in patients with high-grade gliomas

Deuterium is a stable, nontoxic isotope used to label glucose, which is then administered as an oral imaging agent.

May 13, 2026

Representative DMI data from a patient with a high-grade glioma. DMI ratio maps pre- and post-treatment show spatial metabolic changes. Deuterium spectra from the tumor and contralateral NABP demonstrate metabolic differences and therapeutic effects.

ISMRM: Kathryn Keenan on collaboration between rads and physicists

By Kate Madden Yee

Along with current ISMRM president Mark Griswold, PhD, Keenan delivered a talk at the opening plenary session of the conference.

May 12, 2026

Kathryn Keenan, PhD

ISMRM: Cardiac MRI key to assessing CVD risk in those with HIV

By Kate Madden Yee

As treatment for HIV has improved, those with the disease are living longer -- and thus may develop other diseases, including CVD.

May 12, 2026

Ismrm Thumbnail

ISMRM: 7T MR spectroscopy uncovers sleep-neurotransmitter dynamics

Study provides insights into the neurochemical basis of sleep disorders in relation to glutamate imbalances.

May 12, 2026

Joshita Majumdar, PhD candidate in electrical and computer engineering, presented a snapshot of 7T MRI research based at the Auburn University Neuroimaging Center in Alabama. Other team members not pictured include Nguyen Phuoc Huynh and Adil Bashir, PhD, both of Auburn’s Samuel Ginn College of Engineering, and Lavanya Sankaran of California Health Sciences University in Fresno, CA.

ISMRM: Fully automated fetal MRI scanning pipeline shows success

By Amerigo Allegretto

Results presented at ISMRM 2026 suggest a fully automated fetal MRI pipeline can perform on par with specialists.

May 12, 2026

Ismrm Graphic Sign

ISMRM: Katja Pinker talks recent advancements in breast MRI

By Amerigo Allegretto

At ISMRM 2026, Katja Pinker, MD, PhD, talks about promising trends and observations in breast MRI that should provide optimism.

May 12, 2026

Katja Pinker, MD, PhD

ISMRM: 7T MRI-compatible piano may measure neural activity

By Amerigo Allegretto

A study shown at ISMRM 2026 shows how a 7T MRI-compatible piano may be applied to measuring brain activity from users.

May 12, 2026

Researchers at ISMRM presented results from a proof-of-concept study showing how a 7T MRI-compatible piano could potentially help take neural measurements.

ISMRM: Functional lung MRI detects asthma treatment responses

Biologic treatment of severe eosinophilic asthma is successful in only 80% of patients and predictive factors for treatment response are not yet available.

May 11, 2026

Representative PREFUL and F-19 MRI results at baseline and three months of a male responder (age: 47). First row: PREFUL ventilation images; Second row: Ventilation defect percentage (VDP) maps; Third row: Flow-volume loop (FVL) maps. VDP changed from 54% to 23% and the FVL score over the whole lung increased from 88% to 98%. Fourth and fifth rows: second breath-hold F-19 ventilation with corresponding VDP map; sixth and seventh rows: sixth breath-hold F-19 ventilation with corresponding VDP map. Second VDP decreased from 26% to 10% and 6th VDP from 16% to 3%.

ISMRM: qMRI deep learning model predicts CE in brain tumors

Researchers work to predict contrast enhancement without gadolinium-based contrast agents.

May 11, 2026

ISMRM: MRI–CT fat phantom update incorporates myosteatosis measurements

Researchers say there's growing interest in quantifying abnormal fat accumulation in skeletal muscle.

May 11, 2026

ISMRM: MRI in Kenya poised for growth, but challenges remain

By Kate Madden Yee

Martin Gathogo, MD, highlighted the obstacles the country faces when it comes to MRI but also its prospects.

May 11, 2026

Ismrm Graphic Sign 2

ISMRM: Pediatric MRI shows potential in low-resource settings

By Amerigo Allegretto

In her ISMRM plenary lecture, Kirsten Donald, MBChB, PhD, shared insights on pediatric MRI use in low-resource settings.

May 11, 2026

Kirsten Donald, MBChB, PhD, shares insights and provides a call to action to ISMRM 2026 attendees on expanding global health initiatives in MR imaging, including pediatric care in low-resource settings.

Page 1 of 223